This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Altimmune UK Limited, Vaxin UK Limited. Active years: 2015-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2023
Title: Innovations by Jean Francois Thaburet in Peptide Formulations
Introduction
Jean Francois Thaburet is an accomplished inventor based in London, GB. With a focus on the field of biochemistry, he holds three patents that demonstrate his innovative contributions to the development of peptide formulations.
Latest Patents
Thaburet's latest patents highlight a groundbreaking advancement in pharmaceutical formulations. His invention of a fluorocarbon-linked peptide formulation presents an aqueous acidic formulation that is suitable for creating a pharmaceutically acceptable product. This formulation comprises a first fluorocarbon-linked peptide that is at least 20 amino acid residues long. Notably, it contains at least 50% hydrophobic amino acid residues and has an isoelectric point greater than or equal to 7. The fluorocarbon-linked peptide is cleverly presented in micelles, enhancing its suitability for medical applications.
Career Highlights
Throughout his career, Jean Francois Thaburet has made significant strides in the biotech industry. He has worked with companies such as Altimmune UK Limited and Vaxin UK Limited, where he applied his expertise in peptide chemistry and formulation development. His dedication to innovation in this field is evident through his patent contributions.
Collaborations
In his professional journey, Thaburet has collaborated with professionals like Carlton Bradley Brown and Bertrand Victor Gilbert Georges. These partnerships have fostered a collaborative spirit in research and development, driving forward the advancements in peptide formulations.
Conclusion
Jean Francois Thaburet's contributions to the field of peptide formulations have reinforced his position as a notable inventor. With his innovative patents, he has paved the way for potential advancements in pharmaceutical applications, improving therapeutic options for medical professionals and patients alike. His work exemplifies the spirit of innovation necessary for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile